Erratum: Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA

Erratum: Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA

Bibliographic Details
Main Authors:	Na Hee Lee, Sung Yoon Cho, Se Hyun Maeng, Tae Yeon Jeon, Young Bae Sohn, Su Jin Kim, Hyung-Doo Park, Dong Kyu Jin
Format:	Article
Language:	English
Published:	Korean Pediatric Society 2013-03-01
Series:	Korean Journal of Pediatrics
Online Access:	http://kjp.or.kr/upload/pdf/kjped-56-143.pdf

Similar Items

Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA
by: Na Hee Lee, et al.
Published: (2012-11-01)

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management
by: Kazuki Sawamoto, et al.
Published: (2020-02-01)

Role of elosulfase alfa in mucopolysaccharidosis IVA
by: Regier DS, et al.
Published: (2016-06-01)

Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01)

Cochlear implantation in a patient with mucopolysaccharidosis IVA
by: Kyoko Nagao, et al.
Published: (2019-08-01)

Pathophysiology of Hip Disorders in Patients with Mucopolysaccharidosis IVA
by: Zhigang Wang, et al.
Published: (2020-04-01)

Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA
by: Cho, T.-J, et al.
Published: (2022)

Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA
by: Víctor J. Álvarez, et al.
Published: (2021-12-01)

Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
by: Tapiero-Rodriguez SM, et al.
Published: (2018-04-01)

Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model
by: Kazuki Sawamoto, et al.
Published: (2019-08-01)

Common N-acetylgalactosamine-6-sulfate sulfatase (GALNS) exon mutations in Brazilian patients with mucopolysaccharidosis IVA (MPS IVA)
by: Tatiana Dieter, et al.
Published: (2007-01-01)

Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA
by: Sharon J. Chin, et al.
Published: (2020-09-01)

Respiratory Dysfunction in Children and Adolescents with Mucopolysaccharidosis Types I, II, IVA, and VI
by: Assel Tulebayeva, et al.
Published: (2020-01-01)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
by: Hsiang-Yu Lin, et al.
Published: (2018-08-01)

Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome).
by: Christoph Kampmann, et al.
Published: (2016-01-01)

Diagnostic journey and impact of enzyme replacement therapy for mucopolysaccharidosis IVA: a sibling control study
by: Can Ficicioglu, et al.
Published: (2020-11-01)

Oxidative profile exhibited by Mucopolysaccharidosis type IVA patients at diagnosis: Increased keratan urinary levels
by: Bruna Donida, et al.
Published: (2017-06-01)

Corrections of diverse forms of lower limb deformities in patients with mucopolysaccharidosis type IVA (Morquio syndrome)
by: Ali Al Kaissi, et al.
Published: (2016-01-01)

Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA
by: Yasutsugu Chinen, et al.
Published: (2014-01-01)

Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy
by: Joan Bertolin, et al.
Published: (2021-09-01)

Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement
by: Bob Stevens, et al.
Published: (2021-09-01)

Clinical and molecular characteristics of colombian patients with mucopolysaccharidosis IVA, and description of a new galns gene mutation
by: Lina Johanna Moreno Giraldo, et al.
Published: (2018-09-01)

Enzyme replacement therapy interruption in mucopolysaccharidosis type IVA patients and its impact in different clinical outcomes
by: Juan Politei, et al.
Published: (2021-03-01)

A novel gene mutation in a Korean patient with Kabuki syndrome
by: Soo Jin Kim, et al.
Published: (2013-08-01)

Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
by: Melita Dvorak-Ewell, et al.
Published: (2010-01-01)

Clinical Presentation and Follow Up of Patients with Mucopolysaccharidosis Type IVA (Morquio A Disease): Single Center Experience
by: Ebru Canda, et al.
Published: (2018-03-01)

Clinical and genetic characteristics of concomitant Mucopolysaccharidosis type IVA and neurogenic bladder in children: two case reports and literature review
by: Zhuhui Ge, et al.
Published: (2021-01-01)

Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model
by: Kazuki Sawamoto, et al.
Published: (2020-09-01)

2014 Korean Guidelines for Appropriate Utilization of Cardiovascular Magnetic Resonance Imaging: A Joint Report of the Korean Society of Cardiology and the Korean Society of Radiology
by: Yeonyee E. Yoon, et al.
Published: (2015-04-01)

Diagnosis and constitutional and laboratory features of Korean girls referred for precocious puberty
by: Doosoo Kim, et al.
Published: (2012-12-01)

Elosulfase alfa for mucopolysaccharidosis type IVA: Real-world experience in 7 patients from the Spanish Morquio-A early access program
by: Guillem Pintos-Morell, et al.
Published: (2018-06-01)

Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study
by: Huey Yin Leong, et al.
Published: (2019-06-01)

Cerebral and occipito-atlanto-axial involvement in mucopolysaccharidosis patients: clinical, radiological, and neurosurgical features
by: Carlo Giussani, et al.
Published: (2018-11-01)

Mucopolysaccharidosis
by: Nicole Ruas Guarany PhD, et al.
Published: (2015-11-01)

A 9-Month-Old with Skeletal Abnormalities and a Consanguineous Sibling with Mucopolysaccharidosis IVA: The Role of Urinary Glycosaminoglycan Testing in Disease Diagnosis and Treatment Monitoring
by: Eric Goldman, et al.
Published: (2021-03-01)

Erratum
by: Jung-Ho Yu, et al.
Published: (2015-05-01)

Radiological characteristics of Kienböck’s disease in the Korean population
by: Sang Ho Kwak, et al.
Published: (2017-01-01)

Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene
by: Rong Li, et al.
Published: (2019-04-01)

Mucopolysaccharidosis VI
by: Juan Politei MD, et al.
Published: (2015-02-01)

Mucopolysaccharidosis VI
by: Harmatz Paul, et al.
Published: (2010-04-01)

Cannot write session to /tmp/vufind_sessions/sess_78j8qlb0skd7oo8m8rvevedq4o